Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding ...
Dr Parikh explained that KEYNOTE-B15 (NCT04700124) is evaluating the role of perioperative enfortumab vedotin (Padcev), an ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The combination of pembrolizumab and maintenance ...
Interim analysis findings showed the perioperative treatment group demonstrated a statistically significant improvement in event-free survival compared with adjuvant radiotherapy, with or without ...
The FDA has approved the first anti-PD-L1-based therapies for treatment of certain PD-L1-positive ovarian cancers. Pembrolizumab (Keytruda, Merck) and pembrolizumab and berahyaluronidase alfa-pmph ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results